Latest Asx News

Liontown Resources has secured a one-year deferral on debt repayments to Ford and halved its spodumene concentrate commitments, unlocking new sales opportunities amid evolving lithium markets.

OzAurum Resources reports exceptional heap leach testwork results at its Mulgabbie North Gold Project, confirming a promising low-cost development path supported by recent high-grade drilling.

Uvre Limited has gained approval for a secondary listing on the New Zealand Stock Exchange, complementing its ASX listing and enhancing access to New Zealand investors. This move aligns with its expanding gold exploration projects across New Zealand.

PYC Therapeutics has reported positive safety outcomes from its Phase 1 trial of PYC-001 for Autosomal Dominant Optic Atrophy, paving the way for a global Phase 1/2 study later this year.

Terra Critical Minerals (ASX – T92) has revealed extensive high-grade silver mineralisation across its 100% owned Mole River project in NSW, highlighting significant polymetallic potential and setting the stage for a major exploration push.

1414 Degrees has acquired exclusive global rights to a patented silicon nanoparticle technology from George Washington University, aiming to revolutionize lithium-ion battery anodes with higher capacity and faster charging. The company also raised $1.214 million to accelerate commercialisation and OEM engagement starting late 2025.

COG Financial Services is raising A$20 million through an institutional placement to acquire an additional 14.08% stake in Fleet Network, increasing its ownership to over 92%. This move is expected to immediately enhance earnings per share and support COG’s strategic growth in novated leasing and salary packaging.

EV Resources reports strong metallurgical results from its Los Lirios Antimony Project, confirming high antimony grades alongside gold and silver by-products, paving the way for fast-track production and strategic alignment with U.S. critical minerals supply chains.

COG Financial Services has increased its ownership in Fleet Network to over 92% through a $23.9 million acquisition, funded by a $20 million equity placement. This move is expected to enhance earnings and maintain a robust balance sheet heading into FY25.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.

Pathkey.AI’s TrialKey platform continues to validate its AI-driven clinical trial success predictions, with September 2025 seeing an average 43.6% share price increase across flagged biotech stocks.

White Cliff Minerals has reported significant new high-grade copper and silver intersections from its 2025 summer drilling at the Danvers prospect, expanding mineralisation beyond historic boundaries at the Rae Copper Project in Nunavut.